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Introduction: Multimodality therapy including extrapleural pneu-
monectomy (EPP), chemotherapy, and radiotherapy (RT) is often
recommended for fit patients with early stage malignant pleural
mesothelioma. Planning RT after an EPP is difficult due to the large
target area, the high doses required to prevent recurrence, and the
proximity of critical structures. We studied patterns of local and
nodal recurrence in patients treated at our institution with EPP and
RT, and whether advanced treatment planning techniques, such as
intensity modulated radiotherapy (IMRT), could have been of po-
tential benefit.
Methods: From 1993 to 2008, 86 patients with malignant pleural
mesothelioma underwent EPP followed by hemithoracic RT (me-
dian dose: 54 Gy). The RT technique included a combination of
photons and electrons to maximize dose to the target, whereas
minimizing dose to normal tissues. After treatment, patients were
followed with serial imaging and patterns of local and nodal failure
were studied.
Results: Median follow-up time for 78 analyzed patients was 17
months. Eight percent were in stage I, 35% stage II, 55% stage III,
and 2% stage IV. Ten percent of all patients developed late grade 3
pulmonary toxicity and no patient died of RT. Fifteen patients failed
in local and/or nodal sites and did not have a distant component to
their failure pattern. Of these 15 patients, 10 failed in regions of dose
inhomogeneity and could have possibly benefited from IMRT.
Conclusions: The photon-electron technique was tolerable, but
IMRT may provide better target coverage in some patients. IMRT’s
advantages must be balanced against the increased risk of fatal
pulmonary toxicity.
Key Words: Mesothelioma, Radiation therapy, Extrapleural pneumo-
nectomy, Patterns of failure, Intensity modulated radiation therapy.
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Malignant pleural mesothelioma (MPM) affects nearly3000 Americans annually and remains a therapeutic
challenge. Most patients present with disease confined to the
ipsilateral hemithorax, and as a result, surgical resection has
historically been a mainstay of treatment. The debate regard-
ing the ideal surgical procedure lingers, but generally the
more aggressive extrapleural pneumonectomy (EPP) has
been felt to yield a more complete resection than pleurec-
tomy/decortication, which is typically reserved for either
stage IA or palliative disease.1 With either of these tech-
niques, however, residual disease typically remains. Aggres-
sive multimodality therapy attempts to control local, regional,
and distant disease. Adjuvant chemotherapy and radiotherapy
(RT) are usually recommended to improve survival. Trimo-
dality therapy combining EPP with chemotherapy and RT has
resulted in median survival rates of 19 to 29 months.2,3
Planning RT for MPM is difficult due to the large
irregularly shaped area at risk, the high doses required to
prevent local recurrence, and the proximity of critical struc-
tures such as the spinal cord, liver, heart, kidney, and con-
tralateral lung. The optimal RT technique is a subject of
controversy. The technique at Memorial Sloan-Kettering
Cancer Center (MSKCC), which has been previously de-
scribed,4,5 uses a combination of photons and electrons. With
this technique, photons treat most of the hemithoracic field,
but blocks are needed to spare critical structures. Electron
beams are used to supplement the photon-blocked regions.
Electrons treat the superficial tissues and spare the deeper
critical organs. Although this technique respects the tolerance
doses for organs at risk, it may potentially underdose regions
deep to the electron field. For example, the paraspinal area
and costophrenic sulcus are regions that are blocked from the
photon beams (and treated superficially with electrons) to
spare the spinal cord and abdomen yet are also areas of
concern for local failure. These regions of dose inhomoge-
neity may have a higher likelihood for local recurrence.
Alternatively, other institutions have used intensity
modulated radiotherapy (IMRT) to overcome the difficulties
of treating such a complex target.6–9 IMRT may result in
better dose distributions by delivering higher doses to the
target while sparing critical tissues.10 The dose to the con-
tralateral lung is a major drawback to IMRT for thoracic
malignancies. In fact, Allen et al.8 reported that six of 13
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patients treated with EPP, IMRT, and chemotherapy for
MPM died of contralateral pneumonitis. This is an unaccept-
able rate of pulmonary toxicity and argues against the use of
IMRT in MPM.
Thus, the best RT technique for post-EPP patients is
still unclear. To help determine which technique is most
appropriate, we studied the patterns of local and nodal recur-
rence in patients treated at our institution with EPP and the
photon-electron combination technique. If tumors were found
to recur in regions of dose inhomogeneity (i.e., deep to the
electron field) then IMRT may prove to be more appropriate.
PATIENTS AND METHODS
This study was approved by the Institutional Review
Board at MSKCC. We retrospectively reviewed MPM cases
treated with EPP followed by photon-electron RT. EPP en-
tailed en bloc resection of the entire pleura, lung, diaphragm,
and pericardium, if necessary. The diaphragm was recon-
structed to prevent herniation of the abdominal contents into
the thorax and to facilitate postoperative RT.
The RT technique has been previously described in
detail.5 Briefly, radiation to the ipsilateral hemithorax began
3 to 6 weeks after EPP and was prescribed to 45 to 54 Gy in
1.8 Gy fractions. The typical field borders were the top of T1
superiorly, the bottom of L2 inferiorly, and the skin laterally.
The medial border was at the contralateral edge of the
vertebral bodies if there was no mediastinal lymph node
involvement and 1.5 to 2.0 cm beyond the vertebral bodies if
there was mediastinal lymph node involvement. Skin bolus to
prevent scar recurrence was typically not used.
An abdominal block was placed at the start of treatment
to shield the liver or stomach from photon irradiation. For
left-sided tumors, a heart block was placed at 19.8 Gy. The
blocked abdominal and cardiac regions were treated with
electron irradiation (1.53 Gy daily). After 41.4 Gy, the medial
field border was moved to the ipsilateral edge of the vertebral
bodies to block the spinal cord; the superior, inferior, and
lateral field borders did not change.
For further analysis of the failures in our patient pop-
ulation, a clinical target volume (CTV) and planning target
volume were identified retrospectively. The CTV included
the ipsilateral chest wall including ribs and intercostal mus-
cles. The planning target volume was a 1 to 2 cm expansion
around the CTV. Although these target volumes were iden-
tified on the computed tomography (CT) simulation scan, the
field borders were typically set according to the anatomic
landmarks specified above. Spinal cord dose was limited to
45 Gy.
Figure 1A shows an axial slice of the isodose distribu-
tion of the photon-electron technique for a patient with
right-sided MPM. Patients were excluded if they had IMRT,
brachytherapy, or intraoperative RT.
After completing therapy, all patients underwent close
surveillance with serial imaging (CT and/or positron emission
tomography scans) approximately every 3 months. Local
failure was defined as recurrent disease noted on imaging in
the ipsilateral hemithorax. Nodal failures included recurrent
disease in mediastinal lymph nodes. Hematogenous metasta-
ses and disease in the contralateral hemithorax or abdominal
peritoneum were considered distant failures.
The CT and/or positron emission tomography images
of patients with local failures were reviewed in detail to
identify the specific location(s) of failure. These sites of
failure were then correlated to the radiation field to assess
their relationship to the photon blocks/electron fields. The
goal was to analyze the patterns of local failure and determine
whether IMRT could potentially have provided better target
coverage and improved local and nodal control. This study
includes patients included in previous reports from MSKCC
and provides an update of our experience on MPM.5,11 Only
those patients who underwent RT at our institution with
appropriate follow-up are included in this analysis.
RESULTS
From 1993 to 2008, 86 patients underwent EPP fol-
lowed by photon-electron RT for MPM at MSKCC. Eight of
the 86 patients terminated RT early because of progressive
disease during RT (six patients) or extreme nausea/dehydra-
tion (two patients) and were excluded from this study. Sev-
enty-eight patients received a median dose of 54 Gy (range,
45–54 Gy) and 30 (38%) of these received preoperative
chemotherapy as well. Median follow-up time was 17 months
for all patients and 30 months for survivors. Demographic
and staging information is listed in Table 1. RT was tolerable
with appropriate medical support, with the exception of the
two patients who stopped RT early due to dehydration. Eight
of the 78 patients (10%) who completed RT developed late
grade 3 pulmonary toxicity and no patient died of RT (grade 5).
The failure pattern for all 78 patients is reported in
Table 2. Of the 78 patients who completed EPP and hemitho-
racic RT, 43 (55%) failed distantly, 26 without and 17 with
local and/or nodal recurrence. These patients were unlikely to
benefit from improved RT techniques. Twenty patients were
without evidence of disease at their last follow-up. The fifteen
remaining patients (19% of the series, 43% of the 35 patients
without distant recurrence) developed local and/or nodal failures
(without distant failures) and are the focus of this study.
Table 3 details the specific sites of the 15 patients who
had only local and/or nodal failures. Twelve patients (15% of
all 78 patients) failed only in local sites, two patients (3%)
failed in local and nodal sites only, and one (1%) failed in
nodal sites only. Only one patient had a scar recurrence in the
lateral chest wall despite not using bolus during RT routinely.
After identifying patients with local and nodal failures,
their follow-up images were thoroughly reviewed to deter-
mine the exact site(s) of failure, which were then correlated
with the RT field. An example is provided in Figure 1. Figure
1A demonstrates the dose distribution with the photon-elec-
tron technique. Tumor recurrence in the posterior chest wall
is seen in Figure 1B, which corresponds to the heterogeneous
dose distribution in Figure 1A. Because of the retrospective
nature of this analysis, it is impossible to estimate the exact
dose to these regions or the effect of variations in radiation
therapy technique among different treating physicians. Figure
1C demonstrates a potential improvement in target coverage
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in the area of local recurrence using a proposed seven-field
IMRT plan.
Fifteen patients had local and/or nodal failures (i.e., did
not fail distantly). Ten of these 15 patients had local or nodal
recurrences in regions of high dose inhomogeneity and could
have possibly benefited from IMRT. Five patients failed in
one or more sites that were all in high dose, homogeneous
areas, and it is not likely that IMRT would have offered an
advantage over the photon-electron technique. Of these 15
patients, one received 45 Gy, four received 50.4 Gy, and 10
received 54 Gy.
DISCUSSION
Local recurrences continue to be a challenge in MPM.
Fifteen (19%) of the 78 patients (43% of the 35 patients
without distant recurrence) developed only local and/or nodal
failures (without distant failures). Fourteen of these 15 pa-
tients received at least 50 Gy. Of the 15 patients with only
local or nodal failures, 10 failed in sites of dose heterogene-
ity. Therefore, only 10 (13%) of 78 patients in this study may
have benefited from the improved target coverage that IMRT
can deliver. Improved surgical techniques may also increase
local control.
Indeed, it is difficult to determine whether our patients
would have benefited from IMRT. IMRT may have prevented
recurrences in the 10 patients with local and nodal recur-
rences in regions of high-dose inhomogeneity because it
would have provided better target coverage. However, in
some patients, MPM has shown resistance to the current
doses of RT and locoregional recurrence may be inevitable
regardless of RT technique. In addition, the improvement in
dose distribution with IMRT may be offset by increased fatal
pneumonitis.
IMRT has the potential to improve locoregional control
rates in MPM as it has shown to have better dose distributions
when compared with conventional techniques in other disease
sites.12–14 Table 4 displays the results of selected institutions’
experience with conventional RT after EPP,11,15–17 and results
FIGURE 1. A, Axial slice of dose distribution for a patient treated with photon-electron radiotherapy (RT). B, Follow-up com-
puted tomography (CT) scan demonstrating tumor recurrence in the posterior chest wall (green arrow). C, Axial slice of dose
distribution for proposed seven-field intensity modulated radiotherapy (IMRT) plan.
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of four institutions’ experience with IMRT after EPP.6,8,18–20
Rice et al.20 reported a 13% locoregional failure rate, whereas
Miles et al.6 found a 46% failure rate. Even if control rates are
improved with IMRT, the fatality rate is concerning. The rate
of fatal radiation pneumonitis ranged from 8 to 46% with
IMRT versus 0% in patients treated with conventional RT
techniques. The radiation dose to the remaining lung has been
implicated as the cause of this unacceptably high rate of
pneumonitis. These studies have hypothesized restrictions on
contralateral lung dose to keep treatment safe, but these
parameters need to be tested in the clinical setting. Helical
tomotherapy may yield lower lung doses than step-and-shoot
IMRT.9 The patients in our study tolerated photon-electron
RT with the appropriate medical support and none died due to
RT-related pulmonary toxicity.
In conclusion, our study has shown that the local and
nodal failure rate of MPM after EPP and photon-electron
radiation therapy is approximately 40%. There was accept-
able toxicity and there were no treatment-related deaths.
IMRT may have improved the target coverage in a subset of
patients (13% of the 78 patients), but it may potentially cause
increased toxicity. Therefore, if physicians use IMRT in these
patients they must be extremely cautious to prevent fatal
pneumonitis.
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